CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Nirali N. Shah, Pamela L. Wolters et al.|Blood|2022Cited by 179
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastomaMeijie Tian, Javed Khan, Adam Cheuk et al.|Journal of Clinical Investigation|2022Cited by 72